These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8937249)

  • 41. Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis.
    Ramesh V; Ansari NA; Jain RK; Salotra P
    Clin Exp Dermatol; 2008 Jan; 33(1):103-5. PubMed ID: 17979988
    [No Abstract]   [Full Text] [Related]  

  • 42. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis.
    Ansari NA; Ramesh V; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1160-2. PubMed ID: 18639311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of the anemia of kala-azar in 68 childhood cases. Specific antiparasitic chemotherapy is the most effective treatment.
    Hiçsönmez G; Ozsoylu S
    Clin Pediatr (Phila); 1977 Aug; 16(8):733-6. PubMed ID: 872484
    [No Abstract]   [Full Text] [Related]  

  • 44. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
    Ramesh V; Saxena U; Misra RS
    Arch Dermatol; 1992 Mar; 128(3):411-2. PubMed ID: 1550382
    [No Abstract]   [Full Text] [Related]  

  • 48. Leishmaniasis chemotherapy--challenges and opportunities.
    Croft SL; Olliaro P
    Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Kala-azar in infants].
    Fournier A; Henninot E; Ducoulombier H; Cousin J; Duhamel M
    J Sci Med Lille; 1971 Mar; 89(3):115-20. PubMed ID: 5126293
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of miltefosine in the treatment of visceral leishmaniasis in children at a tertiary care hospital of Karachi.
    Humayun KN; Saleem T; Khalid U; Jehan F; Soofi S
    J Pak Med Assoc; 2010 Jun; 60(6):489-91. PubMed ID: 20527651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Visceral leishmaniasis and acute lymphoblastic leukemia B: what is the relationship?].
    El Youssi H; Touaoussa A; Bergui I; Bougrine N; Moncef ; Amrani H
    Pan Afr Med J; 2015; 20():53. PubMed ID: 26090011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 54. New therapy for visceral leishmaniasis.
    Wkly Epidemiol Rec; 2002 Jun; 77(25):210-2. PubMed ID: 12132132
    [No Abstract]   [Full Text] [Related]  

  • 55. Miltefosine for visceral leishmaniasis.
    Sherwood JA
    N Engl J Med; 2000 Mar; 342(12):895. PubMed ID: 10733377
    [No Abstract]   [Full Text] [Related]  

  • 56. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
    Thakur CP; Sinha PK
    J Trop Med Hyg; 1989 Dec; 92(6):383-5. PubMed ID: 2607570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP; Thakur S; Narayan S; Sinha A
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of visceral leishmaniasis in 2004.
    Murray HW
    Am J Trop Med Hyg; 2004 Dec; 71(6):787-94. PubMed ID: 15642973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
    Sundar S; Kumar P; Makharia M; Goyal A; Rogers M; Gibbs D; Murray H
    Clin Infect Dis; 1998 Jul; 27(1):215-6. PubMed ID: 9675482
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
    Murray HW
    Future Microbiol; 2010 Sep; 5(9):1301-3. PubMed ID: 20860475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.